yet treatment remains an area for improvement.1As of 2019, female breast cancer has the highest rates of new diagnoses and is the second highest in number of cancer-related deaths in women, after lung cancer (figure 1).2About 1 of every 8 women will be given a diagnosis...
Although large-scale studies are still needed to confirm their effectiveness, the newest FDA-approved treatments for fibromyalgia include Quell and milnacipran. Quell is an over-the-counter transcutaneous electrical nerve stimulator intended to be used for pain relief. Milnacipran is a serotonin and ...
"I'm happy that my team's research is starting to shed light on what might be causing cognitive problems in patients with cancer," Janelsins said, "and I'm hopeful that we'll be able to come up with treatments in the future." More information:AnnaLynn M. Williams et al. Associations...
Public perception of propylparaben safety is clouded by the results of a controversial 2004 study that connected parabens and breast cancer. Philippa Darbre, professor emeritus in the School of Biological Sciences at the University of Reading in Great Britain, who led the study, maintains ...
for the elderly and for those relapsing with an aggressive clinical course: elderly patients may better tolerate moAbs than other drugs in advanced stage disease; for high-risk, rapidly evolving relapses, antibody therapy may be more feasible in a short time than other cellular treatments. ...